Ajay Gopal, MD
Enriched profileProfessor, Division of Hematology and Oncology, University of Washington School of Medicine; Stephen Hans Petersdorf, MD Endowed Chair in Cancer Care, UW Medicine · University of Washington School of Medicine
Ajay Gopal is Professor, Division of Hematology and Oncology, University of Washington School of Medicine; Stephen Hans Petersdorf, MD Endowed Chair in Cancer Care, UW Medicine at University of Washington School of Medicine. OpenAlex indexes 619 publications with 17,838 citations (h-index 59); ClinicalTrials.gov lists 25 registered studies with this person as an investigator.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Ajay Gopal is Professor, Division of Hematology and Oncology, University of Washington School of Medicine. The public record shows 619 publications with 17,838 citations (h-index 59), centered on Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Hematopoietic Stem Cell Transplantation. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 11 companies, 5 NIH-funded awards (2000–2026).
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Lymphoma Diagnosis and Treatment
- 25 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 208.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:
- Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
Sponsor: University of Washington
- Study of SGR-1505 in Mature B-Cell Neoplasms
Sponsor: Schrödinger, Inc.
Industry payments
Updated 18 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Genmab U.S., Inc.Program year20252 payments
- Incyte CorporationProgram year20251 payment
- ADC Therapeutics America, Inc.Program year20244 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Kinase inhibitor100%Brukinsa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
5 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
Congress activity
Updated 18 Oct 2026
111 congress contributions (2004–2025) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- Causes of death in chronic lymphocytic leukemia/small lymphocytic lymphoma during the novel agent era: A population-based analysis
ASH Annual Meeting
ASH2025Co-author - Long term safety and long term disease control of oral ixazomib and short-course rituximab in untreated iNHL
ASH Annual Meeting
ASH2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology
Article2026 - Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.
American journal of hematology
Clinical Trial2026 - "Immunologic dream team": BiTEs periallotransplant to redirect donor lymphocytes toward GVL.
Blood advances
Case Report2026 - Pretargeted Anti-CD20 Radioimmunotherapy with scFv Fusion Protein Safely Combines with BEAM and ASCT in Patients with High-risk B-cell Lymphomas.
Molecular cancer therapeutics
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent LymphomaArticle1,069 citations2014
- 03Diagnosis and Management of Multiple MyelomaArticle1,033 citations2022
- 04
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/ajay-gopal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
fredhutch.org/en/faculty-lab-directory/gopal-ajay.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗ - Other
fredhutch.org/en/news/center-news/2026/10/oncology-insights-ajay-gopal-petros-grivas-episode-23.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fredhutch.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Emory University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - BS
Zoology, Duke University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Board Certification in Medical Oncology
American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - FACP
Fellow of the American College of Physicians
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Secondary affiliations
appointments beyond the home institution- Professor in the Clinical Research Division
Fred Hutchinson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Medical Director of Clinical Research
Hematology Malignancies/Hematology, Fred Hutchinson Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗ - Medical Director
Clinical Research Support, Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Media & interviews
press, podcasts and appearances- Podcast appearance: 'Oncology Insights' Episode 23 with Dr. Petros Grivas discussing lymphoma innovation
clinical trials and leadership
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fredhutch.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Irl Hirsch, MD
University of Washington School of Medicine
Douglas Zatzick, MD
University of Washington School of Medicine
Evan Yu, MD
University of Washington School of Medicine
Seth Steinberg, PhD
National Cancer Institute (NCI)
Gilles Salles
Memorial Sloan Kettering Cancer Center
Wyndham Wilson, MD
National Cancer Institute (NCI)
Julie Vose, MD
University of Nebraska Medical Center